We don’t support this browser anymore.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

Skip to main content
  • Register
  • Help
  • Contact us

Avanos Medical Inc (AVNS) USD0.01

Sell:$32.62 Buy:$32.66 Change: $0.21 (0.65%)
Market closed |  Prices as at close on 25 October 2021 | Switch to live prices |
Change: $0.21 (0.65%)
Market closed |  Prices as at close on 25 October 2021 | Switch to live prices |
Change: $0.21 (0.65%)
Market closed |  Prices as at close on 25 October 2021 | Switch to live prices |
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

Avanos Medical, Inc. is a medical technology company. The Company provide a portfolio of product offerings focused on chronic care and pain management. Its chronic care is a portfolio of products that includes digestive health products and respiratory health products. Its pain management is a portfolio of products that includes acute pain products and interventional pain solutions. Its digestive health products include its MIC-KEY enteral feeding tubes, CORPAK patient feeding solutions and NEOMED neonatal and pediatric feeding solutions. Its respiratory health products include closed airway suction systems, oral care and other airway management devices under the BALLARD, MICROCUFF and ENDOCLEAR brands. Its acute pain product includes ON-Q and AMBIT surgical pain pumps and GAME READY cold and compression therapy systems. Its interventional pain solutions provide minimally invasive pain-relieving therapies, such as its COOLIEF pain relief therapy.

Contact details

5405 Windward Parkway
United States
+1 (678) 4259273

Important dates

Future events
There are no future events available.
Past events
There are no past events available.

General stock information

Short code:
Market cap:
$1.56 billion
Shares in issue:
48.12 million
Health Care Supplies
New York Stock Exchange
United States
US dollar

Key personnel

  • Joseph Woody
    Chief Executive Officer, Director
  • Michael Greiner
    Chief Financial Officer, Senior Vice President
  • Michelle Scharfenberg
    Senior Vice President, Chief Ethics and Compliance Officer
  • Moji James
    Senior Vice President, General Counsel
  • William Haydon
    Senior Vice President and General Manager, Pain Management
  • S. Ross Mansbach
    Senior Vice President, Company Secretary
  • David Ball
    Senior Vice President - Global Supply Chain and Procurement
  • Arjun Sarker
    Senior Vice President - International

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by Reuters.


The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.